Improve your sales insight using AI
Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
New standards launched to improve public involvement in research
New national standards to improve the quality of public involvement in research.
Old sales techniques are history and sales forces must adapt
Despite all the rhetoric about multichannel marketing, patient centricity and the inexorable rise of digital, the most effective sales channel is still standing ‘two...
How to concentrate sales efforts in the right place
Right place, right time In part two of a series looking at the effective use of data, Dr Graham Leask addresses how to concentrate sales...
Sales force awakens to boost ROI
Sales force awakens
Karen Bell, Director of Business Development at Ashfield Commercial and Clinical UK, on maximising return on investment. Sales force effectiveness (SFE) is about...
The rise of digital marketing: pharma and social media
Social media is a prerequisite for most businesses, but how has the historically reticent pharma industry been adapting?
Graeme Smith
Managing Partner, Fortis Pharma Consulting
The highly–regulated...
Marketing Focus: the shift from treatment to prevention
Read part one of Setting the scene in the June edition of Pf Magazine here. PART TWO: Setting the scene
Dr Graham Leask and Stewart Adkins...
Marketing Focus: helping modern marketeers to thrive
PART ONE: Setting the scene Introducing a new series of ‘Marketing Focus’ articles, helping modern marketeers to thrive in the changing healthcare environment. In the first...
Latest articles
Reputation control: changing perceptions of pharma
Amanda Barrel investigates pharma’s reputation, self-regulation, compliance and how pharma can change perceptions of the work it does. Top 5 Takeaways
1 Only 57% of people...
Medicines and Medical Devices Bill: Getting it right for all
With the Medicines and Medical Devices Bill heading through Parliament, Claudia Rubin asks what is required to get this legislation right? The Government would like...
Popular articles
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Boost to COVID-19 vaccine and therapy research
COVID-19 vaccine and therapy research has been boosted by six new projects in rapid response. The six new studies into the novel coronavirus have...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Synairgen to start trial of SNG001 in COVID-19
Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...